Intracranial Pressure Monitors Market Size, Share & Industry Analysis, By Product Type (Invasive, Non-Invasive), By Application (Traumatic brain injury, Intracerebral haemorrhage, Meningitis), By End-user (Hospitals, Clinics, Private medical offices, Trauma centres, Government and research organizations) And Regional Forecast, 2024-2032

Intracranial pressure (ICP) monitoring is a diagnostic test that helps doctor in determing if high or low cerebrospinal fluid (CSF) pressure is triggering symptoms. The test measures the pressure in head by directly using a small pressure-sensitive probe that is inserted through the skull. ICP is measured in two ways. One way is to place a small, hollow tube (catheter) into the fluid-filled space in the brain (ventricle) or a hollow device (bolt) is placed through the skull into the space just between the skull and the brain The rising prevalence of neurological disorders and traumatic accidents are the major factors driving the intracranial pressure monitors market. In 2021, per BIAA (Brain injury association of America), a person in the U.S. sustains a brain injury every nine seconds, concluding more than 3.5 million injuries each year.

The rising prevalence of neurological disorders and rise in technological advancement is estimated to drive the intracranial pressure monitors market over the forecast duration. For instance, Integra has launched Camino Flex catheters which perform multifunctional roles which has also increased the scope for advancement for other competitors. Combined with this, AURA monitor devices have completely disrupted the market with their first wireless device.  A fitness tracker with bio impedance technology which measures the body composition, activities and heart rate,

However, higher price associated with intracranial pressure monitors is estimated to restrain the market growth during the forecast period. Also lack of skilled medical professionals for proper handling of these devices is restraining the market as they are inserted inside the skull so they increase the chance of risks like- infection, swelling and hemorrhage, thus hindering the industry growth.

Market Segmentation:

Globally, the intracranial pressure monitors market can be segmented into product type, application, end-user and region. Based on product type, the market has been divided into invasive (External ventricular drainage, Micro transducer ICP Monitoring) and non-invasive (MRI/CT, Fundoscopy, Transcranial Doppler Ultrasonography, Tympanic Membrane Displacement (TMD). On the basis of application, the market can be segmented into Traumatic brain injury, Intracerebral hemorrhage, Meningitis, others.  Based on segmentation of end-user, the market can be categorized into hospitals, Clinics, Private medical offices, Trauma centers, Government and research organizations.

Geographically, the intracranial pressure monitors market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:

Some of the major companies that are present in the intracranial pressure monitors market are Codman & Shurtleff Incorporated, Sophysa, Gaeltec Devices Limited, Integra Lifesciences Co., Raumedic AG, VITTAMED, Orsan Medical Technologies, Haiying Medical, and others prominent players

Key Insights:

• Technological Advancements in Intracranial Pressure Monitors Market


• Key Industry Developments – Merger, Acquisitions, and Partnerships


• Key Product Launches


• Overview of Regulatory Scenario – Key Country/Region


• COVID-19 Impact on Intracranial Pressure Monitors Market

Regional Analysis:

Based on segmentation of region, the Intracranial Pressure Monitors market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to dominate the market in 2021 and is estimated to retain its leading position over the forecast duration. Factors such as higher funding in research and development, increased healthcare infrastructure, high adoption of advanced ICP monitoring devices, and the presence of large patient pool is attributing to the growth of the market in North America. Owing to the increasing cases, USA has a large manufacturing base for the monitoring devices which is fueling the market growth in North America. The European region and APAC region is estimated to secure the second and third leading position in the market respectively, owed to the factors such as large number of cases related to brain injuries and dysfunctionalities among others. These factors combined with others are estimated to augment the market growth in Europe and APAC regions for the coming years.

Greater initiatives are being undertaken by the governments, and presence of various well-established hospitals and critical care centers are likely to boost the growth of Asia Pacific. The market growth in the region is also supplemented by increasing old age population and increasing disposable incomes in countries such as India and China. The market in countries of Latin America and Middle East and Africa are expected to grow at a slower rate as compared to other regions owed to limited penetration of advanced medical devices.

Segmentation

Intracranial Pressure Monitors Market Industry Developments

• In May, 2019, the U.S. Food and Drug Administration (FDA) announced a class I recall of Integra LifeSciences’ LimiTorr Volume Limiting Cerebrospinal Fluid (CSF) Drainage System and its MoniTorr Intracranial Pressure (ICP) External CSF Drainage and Monitoring Systems.


• Among the key players, Branchpoint Technologies in 2018 announced that the United States Food and Drug Administration (FDA) had granted clearance for its AURA ICP Monitoring System